Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | KDM5A | P29375 | 8/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 7/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.40 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10136011 | 0.88 | DNM1 (0.47) | DNM1CASP2FAAHCNR1KMT2A | |
| SCHEMBL30890794 | 0.85 | DNM1 (0.56) | DNM1EPHX2CASP2FAAHKDM4A | |
| SCHEMBL10787440 | 0.85 | AKR1B1 (0.50) | KDM5AKDM4CMEN1KMT2A | |
| SCHEMBL7897141 | 0.84 | CASP2 (0.62) | DNM1EPHX2CASP2FAAHSLC6A5 | |
| SCHEMBL25353415 | 0.83 | DNM1 (0.62) | DNM1EPHX2FAAHCNR1CNR2 | |
| SCHEMBL6860236 | 0.83 | DNM1 (0.50) | DNM1EPHX2CASP2FAAHCNR1 | |
| SCHEMBL585370 | 0.83 | CASP2 (0.56) | DNM1EPHX2CASP2FAAHCNR1 | |
| SCHEMBL27665153 | 0.82 | KDM5A (0.53) | DNM1EPHX2CASP2KDM5AKDM4C | |
| Hydrochloric Acid SCHEMBL27665152 | 0.81 | KDM5A (0.51) | DNM1EPHX2CASP2KDM5AKDM4C | |
| SCHEMBL26037662 | 0.81 | CASP2 (0.58) | DNM1EPHX2CASP2FAAHCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1895979-B1 | COSMETICS COMPRISING A MODIFIED ORGANOPOLYSILOXANE | DOW CORNING TORAY CO LTD (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-8147854-B2 | Cosmetics comprising a modified organopolysiloxane | DOW CORNING TORAY COMPANY, LTD. (JP) | 2012-04-03 | — | — | US | disclosed |
| EP-1907068-B1 | GELLING AGENT COMPRISING A MODIFIED ORGANOPOLYSILOXANE | DOW CORNING TORAY CO LTD (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-8013094-B2 | Gelling agents and gelatinous compositions | DOW CORNING TORAY COMPANY, LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20100029862-A1 | Gelling Agents And Gelatinous Compositions | DOW CORNING TORAY COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100028391-A1 | Cosmetics Comprising A Modified Organopolysiloxane | DOW CORNING TORAY COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028391-A1 | Cosmetics Comprising A Modified Organopolysiloxane | H1-0, H1-2, CHRM1 | DNM1 4338/4885EPHX2 1691/4885CASP2 4144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.